Summit on Advanced Therapeutics - Summit Spotlight: Focus on Advanced Therapeutics - Implications for Pharmacy Practice and Medication Use Policy
|
There is no CE associate with this activity |
This session was part of ASHP’s Summit on Advanced Therapeutics at Pharmacy Futures 2025. There is no CE associated with this activity.
Activity Overview
This session explores the evolving role of advanced therapeutics in patient care and examines strategies health systems are using to address their integration. Faculty highlight challenges to operationalizing these therapies within existing medication-use processes and walk through the complete process of implementation, from financial considerations and policy development to clinical monitoring, process sustainment, and optimization.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
-
Introduction and Announcements
-
Presentation
-
Questions, Answers, and Discussion
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
-
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.